Gelteq Limited Ordinary Shares (GELS) Research

Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.

Market snapshot

Symbol
GELS
Price
$1.04
Day change
-8.77%
Market cap
$13.6M
52-week range
0.387-2.02
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Aytu BioPharma, Inc. (AYTU)
  • Bullfrog AI Holdings, Inc. Common Stock (BFRG)
  • Biofrontera Inc. (BFRI)
  • BioNexus Gene Lab Corp. (BGLC)
  • Cocrystal Pharma, Inc. (COCP)
  • Evogene Ltd. (EVGN)
  • Imunon, Inc. (IMNN)
  • Immuron Limited (IMRN)

Recent insider activity

  • WYNNE Paul Michael — trade (0 shares) on 2026-03-18
  • Szewach Simon H — trade (0 shares) on 2026-03-18
  • Szewach Simon H — trade (65000 shares) on 2026-07-01
  • Karp Bradley Glenn — trade (0 shares) on 2026-03-18
  • Givoni Nathan J — trade (0 shares) on 2026-03-18

Open Gelteq Limited Ordinary Shares (GELS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.